US Stock MarketDetailed Quotes

RLAY Relay Therapeutics

Watchlist
  • 8.940
  • -0.120-1.32%
Close Jul 26 16:00 ET
  • 8.940
  • 0.0000.00%
Post 20:01 ET
1.19BMarket Cap-3399P/E (TTM)

Relay Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relay Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

10.01M

+4327.88%
EPS(YoY)

-0.62

+20.51%
Analyst Rating

Strong Buy

Jul 26, 2024

Relay Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 100.000K--
--2024/Q2-- / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--
Feb 22, 20242023/Q40.000 / 610.000K--
Nov 2, 20232023/Q325.202M / 412.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 100.000K--
--2024/Q2-- / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--
Feb 22, 20242023/Q40.000 / 610.000K--
Nov 2, 20232023/Q325.202M / 412.000K--

Unlock Free Earnings Estimates

Relay Therapeutics Earnings Reports

  • Relay Therapeutics | 10-Q: Quarterly report

    May 2 16:20 ET

  • Relay Therapeutics | 10-K: Annual report

    Feb 22 16:25 ET

  • Relay Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:17 ET

  • Relay Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:25 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg